Digestosan en es it fr

Digestosan Brand names, Digestosan Analogs

Digestosan Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Digestosan Chemical_Formula


Digestosan RX_link


Digestosan fda sheet

Digestosan FDA

Digestosan msds (material safety sheet)

Digestosan MSDS

Digestosan Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Digestosan Molecular Weight

314.405 g/mol

Digestosan Melting Point

69-70 oC

Digestosan H2O Solubility

24.7 mg/mL

Digestosan State


Digestosan LogP


Digestosan Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Digestosan Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Digestosan Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Digestosan Absorption

Approximately 50% bioavailability orally.

Digestosan side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Digestosan Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Digestosan Organisms Affected

Humans and other mammals